Cancer
Researchers at the Aristotle University of Thessaloniki have shed light on the characteristics of hematological cancer stem cells (HCSCs), a subpopulation of cells within hematological cancers that enhance malignancy and render treatment more challenging. By examining the existing literature, the study aimed to identify potential targets for improving immunotherapy clinical
Cancer
New research conducted by a team from the Huazhong University of Science and Technology in Wuhan, People's Republic of China, has made a significant breakthrough in cancer gene therapy. The team's study, published in Oncogene, has identified complement component 1q subcomponent binding protein (C1QBP) as a
Biden, Joe
Former President Joe Biden, 82, is currently undergoing radiation therapy and hormone treatment for an aggressive form of prostate cancer. Diagnosed earlier this year, Biden's cancer had spread to his bones, prompting his team to announce the disease's progression in May. According to his office, Biden&
Cancer research
A groundbreaking study from the University Libre de Bruxelles in Brussels, Belgium, has shed new light on the complex mechanisms underlying thyroid cancer. The research, published in the journal Cells, found that the RNA-binding protein Dicer1 plays a pivotal role in the development and progression of papillary thyroid carcinoma (PTC)
Cancer research
A recent study from the Belgian Cancer Registry evaluated the effects of the COVID-19 pandemic on lung cancer diagnosis, treatment, mortality, and survival in Belgium. The research analyzed 29,721 lung cancer patients diagnosed between 2017 and 2020, with a focus on those diagnosed in 2020 during the pandemic. The
Cancer research
Studies have shown that radiotherapy is a valuable treatment option for patients with extracranial oligometastatic non-small cell lung cancer (NSCLC), with significant improvements in survival rates. Researchers at Dartmouth-Hitchcock Medical Center evaluated the clinical benefit of radiotherapy in NSCLC patients using the European Society of Medical Oncology (ESMO) magnitude of
Cancer research
A new study has made a significant breakthrough in the field of prostate cancer treatment by identifying genetic variants that make some patients more sensitive to radiation in specific parts of the rectum. Led by University of Manchester scientists, the research combined genetic data with detailed spatial maps of where
Biden, Joe
As part of a comprehensive treatment plan for aggressive prostate cancer, former US President Joe Biden is currently undergoing radiation therapy and hormone treatment. The 82-year-old's post-presidential office announced in May that he had been diagnosed with prostate cancer, which had spread to his bone. This new phase
Biden, Joe
Former US President Joe Biden is currently receiving radiation therapy as part of his treatment for prostate cancer. According to his spokesman, the 82-year-old is also undergoing hormone treatment, but no further details were provided. Biden's radiation therapy is expected to span five weeks, marking a new stage
Biden, Joe
Former US President Joe Biden has commenced radiation therapy to address an aggressive form of prostate cancer that has spread to his bones, his spokesperson confirmed in May. The cancer diagnosis was revealed in the same month, and given its hormone-sensitive nature, the president is expected to respond well to
Cancer research
Imagine your body's immune defenses as a city, with lymph nodes as the hubs where police and firefighters gather fresh intel to launch their attack on cancer cells. Recent research is challenging the long-standing practice of removing lymph nodes during cancer surgery. Surgeons have traditionally removed these nodes
Cancer treatment
Research presented in a recent narrative review has shed light on the effectiveness of ultrahypofractionated radiotherapy in treating localized prostate cancer. The study compared single-session and two-session approaches in Stereotactic Body Radiation Therapy (SBRT) and high-dose-rate (HDR) brachytherapy, highlighting the potential benefits of these ultra-hypofractionated strategies in delivering high-precision ablative
